Paul Y. Song, M.D. is currently Chief Medical Officer of ATGen Global in Seoul, South Korea, and also the Chief Medical Officer of Cynvenio Biosystems in Westlake Village, CA. Dr. Song remains as a Senior Adviser at Berg Pharma, where he previously served as its Chief Medical Officer for the company’s first four years. He was most recently on the faculty at the Samuel Oschin Cancer Center at Cedars Sinai Medical Center in the department of radiation oncology. He is also the Executive Chairman of the Courage Campaign, a progressive online organization of 1.2 million members. In addition, Dr. Song serves on the board of Physicians for a National Health Program, People for the American Way, The Asian Pacific American Institute for Congressional Studies, and The Eisner Pediatric and Family Medical Center. Dr. Song graduated with honors from the University of Chicago and received his M.D. degree from George Washington University. He completed his residency in radiation oncology at the University of Chicago and did a brachytherapy fellowship at the Institute Gustave Roussy in Villejuif, France.